Nuo Therapeutics, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2018
November 16, 2018 at 05:11 pm EST
Nuo Therapeutics, Inc. announced earnings results for the third quarter ended September 30, 2018. For the third quarter, the company announced total revenue was USD 260,280 compared to USD 162,196 a year ago. Operating loss was USD 411,794 compared to USD 1.375 million a year ago. Net loss was USD 649,878 compared to USD 1.376 million a year ago. Basic loss per share was USD 0.03 compared to USD 0.09 a year ago. For the nine months, total revenue was USD 558,532 compared to USD 523,539 a year ago. Operating loss was USD 1.662 million compared to USD 6.970 million a year ago. Net loss was USD 1.910 million compared to USD 6.981 million a year ago. Basic loss per share was USD 0.08 compared to USD 0.59 a year ago.